Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations
• Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected be...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Greter, Helena [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement - Li, Yaoyao ELSEVIER, 2022, Amsterdam |
|---|---|
| Übergeordnetes Werk: |
volume:39 ; year:2021 ; number:3 ; day:15 ; month:01 ; pages:580-587 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.vaccine.2020.12.003 |
|---|
| Katalog-ID: |
ELV052624242 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV052624242 | ||
| 003 | DE-627 | ||
| 005 | 20230624185024.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.vaccine.2020.12.003 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001252.pica |
| 035 | |a (DE-627)ELV052624242 | ||
| 035 | |a (ELSEVIER)S0264-410X(20)31566-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 630 |a 640 |q VZ |
| 084 | |a 48.00 |2 bkl | ||
| 100 | 1 | |a Greter, Helena |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations |
| 264 | 1 | |c 2021 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected benefits. • Logistics, protocol adherence, and compliance were considered key areas for roll-out. • A clear communication strategy, adjusted to different stakeholders, was considered critical for smooth implementation. | ||
| 650 | 7 | |a Heterologous vaccine regimen |2 Elsevier | |
| 650 | 7 | |a Acceptance |2 Elsevier | |
| 650 | 7 | |a Immunization |2 Elsevier | |
| 650 | 7 | |a Vaccine |2 Elsevier | |
| 650 | 7 | |a Implementation |2 Elsevier | |
| 700 | 1 | |a Ivol, Sabrina |4 oth | |
| 700 | 1 | |a Oriol Mathieu, Valérie |4 oth | |
| 700 | 1 | |a Erismann, Séverine |4 oth | |
| 700 | 1 | |a Prytherch, Helen |4 oth | |
| 700 | 1 | |a Steinmann, Peter |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Li, Yaoyao ELSEVIER |t Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |d 2022 |g Amsterdam |w (DE-627)ELV007884451 |
| 773 | 1 | 8 | |g volume:39 |g year:2021 |g number:3 |g day:15 |g month:01 |g pages:580-587 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.vaccine.2020.12.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-FOR | ||
| 936 | b | k | |a 48.00 |j Land- und Forstwirtschaft: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 39 |j 2021 |e 3 |b 15 |c 0115 |h 580-587 |g 8 | ||
| author_variant |
h g hg |
|---|---|
| matchkey_str |
greterhelenaivolsabrinaoriolmathieuvalri:2021----:eeooosacnrgmntkhleacpacadmlm |
| hierarchy_sort_str |
2021 |
| bklnumber |
48.00 |
| publishDate |
2021 |
| allfields |
10.1016/j.vaccine.2020.12.003 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001252.pica (DE-627)ELV052624242 (ELSEVIER)S0264-410X(20)31566-8 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.00 bkl Greter, Helena verfasserin aut Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected benefits. • Logistics, protocol adherence, and compliance were considered key areas for roll-out. • A clear communication strategy, adjusted to different stakeholders, was considered critical for smooth implementation. Heterologous vaccine regimen Elsevier Acceptance Elsevier Immunization Elsevier Vaccine Elsevier Implementation Elsevier Ivol, Sabrina oth Oriol Mathieu, Valérie oth Erismann, Séverine oth Prytherch, Helen oth Steinmann, Peter oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:39 year:2021 number:3 day:15 month:01 pages:580-587 extent:8 https://doi.org/10.1016/j.vaccine.2020.12.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 39 2021 3 15 0115 580-587 8 |
| spelling |
10.1016/j.vaccine.2020.12.003 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001252.pica (DE-627)ELV052624242 (ELSEVIER)S0264-410X(20)31566-8 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.00 bkl Greter, Helena verfasserin aut Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected benefits. • Logistics, protocol adherence, and compliance were considered key areas for roll-out. • A clear communication strategy, adjusted to different stakeholders, was considered critical for smooth implementation. Heterologous vaccine regimen Elsevier Acceptance Elsevier Immunization Elsevier Vaccine Elsevier Implementation Elsevier Ivol, Sabrina oth Oriol Mathieu, Valérie oth Erismann, Séverine oth Prytherch, Helen oth Steinmann, Peter oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:39 year:2021 number:3 day:15 month:01 pages:580-587 extent:8 https://doi.org/10.1016/j.vaccine.2020.12.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 39 2021 3 15 0115 580-587 8 |
| allfields_unstemmed |
10.1016/j.vaccine.2020.12.003 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001252.pica (DE-627)ELV052624242 (ELSEVIER)S0264-410X(20)31566-8 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.00 bkl Greter, Helena verfasserin aut Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected benefits. • Logistics, protocol adherence, and compliance were considered key areas for roll-out. • A clear communication strategy, adjusted to different stakeholders, was considered critical for smooth implementation. Heterologous vaccine regimen Elsevier Acceptance Elsevier Immunization Elsevier Vaccine Elsevier Implementation Elsevier Ivol, Sabrina oth Oriol Mathieu, Valérie oth Erismann, Séverine oth Prytherch, Helen oth Steinmann, Peter oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:39 year:2021 number:3 day:15 month:01 pages:580-587 extent:8 https://doi.org/10.1016/j.vaccine.2020.12.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 39 2021 3 15 0115 580-587 8 |
| allfieldsGer |
10.1016/j.vaccine.2020.12.003 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001252.pica (DE-627)ELV052624242 (ELSEVIER)S0264-410X(20)31566-8 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.00 bkl Greter, Helena verfasserin aut Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected benefits. • Logistics, protocol adherence, and compliance were considered key areas for roll-out. • A clear communication strategy, adjusted to different stakeholders, was considered critical for smooth implementation. Heterologous vaccine regimen Elsevier Acceptance Elsevier Immunization Elsevier Vaccine Elsevier Implementation Elsevier Ivol, Sabrina oth Oriol Mathieu, Valérie oth Erismann, Séverine oth Prytherch, Helen oth Steinmann, Peter oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:39 year:2021 number:3 day:15 month:01 pages:580-587 extent:8 https://doi.org/10.1016/j.vaccine.2020.12.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 39 2021 3 15 0115 580-587 8 |
| allfieldsSound |
10.1016/j.vaccine.2020.12.003 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001252.pica (DE-627)ELV052624242 (ELSEVIER)S0264-410X(20)31566-8 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.00 bkl Greter, Helena verfasserin aut Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected benefits. • Logistics, protocol adherence, and compliance were considered key areas for roll-out. • A clear communication strategy, adjusted to different stakeholders, was considered critical for smooth implementation. Heterologous vaccine regimen Elsevier Acceptance Elsevier Immunization Elsevier Vaccine Elsevier Implementation Elsevier Ivol, Sabrina oth Oriol Mathieu, Valérie oth Erismann, Séverine oth Prytherch, Helen oth Steinmann, Peter oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:39 year:2021 number:3 day:15 month:01 pages:580-587 extent:8 https://doi.org/10.1016/j.vaccine.2020.12.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 39 2021 3 15 0115 580-587 8 |
| language |
English |
| source |
Enthalten in Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement Amsterdam volume:39 year:2021 number:3 day:15 month:01 pages:580-587 extent:8 |
| sourceStr |
Enthalten in Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement Amsterdam volume:39 year:2021 number:3 day:15 month:01 pages:580-587 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Land- und Forstwirtschaft: Allgemeines |
| institution |
findex.gbv.de |
| topic_facet |
Heterologous vaccine regimen Acceptance Immunization Vaccine Implementation |
| dewey-raw |
630 |
| isfreeaccess_bool |
false |
| container_title |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
| authorswithroles_txt_mv |
Greter, Helena @@aut@@ Ivol, Sabrina @@oth@@ Oriol Mathieu, Valérie @@oth@@ Erismann, Séverine @@oth@@ Prytherch, Helen @@oth@@ Steinmann, Peter @@oth@@ |
| publishDateDaySort_date |
2021-01-15T00:00:00Z |
| hierarchy_top_id |
ELV007884451 |
| dewey-sort |
3630 |
| id |
ELV052624242 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV052624242</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624185024.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.vaccine.2020.12.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001252.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV052624242</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0264-410X(20)31566-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">48.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Greter, Helena</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected benefits. • Logistics, protocol adherence, and compliance were considered key areas for roll-out. • A clear communication strategy, adjusted to different stakeholders, was considered critical for smooth implementation.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Heterologous vaccine regimen</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Acceptance</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Implementation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ivol, Sabrina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Oriol Mathieu, Valérie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Erismann, Séverine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Prytherch, Helen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steinmann, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Li, Yaoyao ELSEVIER</subfield><subfield code="t">Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV007884451</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:3</subfield><subfield code="g">day:15</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:580-587</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.vaccine.2020.12.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-FOR</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">48.00</subfield><subfield code="j">Land- und Forstwirtschaft: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2021</subfield><subfield code="e">3</subfield><subfield code="b">15</subfield><subfield code="c">0115</subfield><subfield code="h">580-587</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
Greter, Helena |
| spellingShingle |
Greter, Helena ddc 630 bkl 48.00 Elsevier Heterologous vaccine regimen Elsevier Acceptance Elsevier Immunization Elsevier Vaccine Elsevier Implementation Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations |
| authorStr |
Greter, Helena |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007884451 |
| format |
electronic Article |
| dewey-ones |
630 - Agriculture & related technologies 640 - Home & family management |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
630 640 VZ 48.00 bkl Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations Heterologous vaccine regimen Elsevier Acceptance Elsevier Immunization Elsevier Vaccine Elsevier Implementation Elsevier |
| topic |
ddc 630 bkl 48.00 Elsevier Heterologous vaccine regimen Elsevier Acceptance Elsevier Immunization Elsevier Vaccine Elsevier Implementation |
| topic_unstemmed |
ddc 630 bkl 48.00 Elsevier Heterologous vaccine regimen Elsevier Acceptance Elsevier Immunization Elsevier Vaccine Elsevier Implementation |
| topic_browse |
ddc 630 bkl 48.00 Elsevier Heterologous vaccine regimen Elsevier Acceptance Elsevier Immunization Elsevier Vaccine Elsevier Implementation |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s i si m v o mv mvo s e se h p hp p s ps |
| hierarchy_parent_title |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
| hierarchy_parent_id |
ELV007884451 |
| dewey-tens |
630 - Agriculture 640 - Home & family management |
| hierarchy_top_title |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007884451 |
| title |
Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations |
| ctrlnum |
(DE-627)ELV052624242 (ELSEVIER)S0264-410X(20)31566-8 |
| title_full |
Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations |
| author_sort |
Greter, Helena |
| journal |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
| journalStr |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
580 |
| author_browse |
Greter, Helena |
| container_volume |
39 |
| physical |
8 |
| class |
630 640 VZ 48.00 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Greter, Helena |
| doi_str_mv |
10.1016/j.vaccine.2020.12.003 |
| dewey-full |
630 640 |
| title_sort |
heterologous vaccine regimen: stakeholder acceptance and implementation considerations |
| title_auth |
Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations |
| abstract |
• Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected benefits. • Logistics, protocol adherence, and compliance were considered key areas for roll-out. • A clear communication strategy, adjusted to different stakeholders, was considered critical for smooth implementation. |
| abstractGer |
• Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected benefits. • Logistics, protocol adherence, and compliance were considered key areas for roll-out. • A clear communication strategy, adjusted to different stakeholders, was considered critical for smooth implementation. |
| abstract_unstemmed |
• Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected benefits. • Logistics, protocol adherence, and compliance were considered key areas for roll-out. • A clear communication strategy, adjusted to different stakeholders, was considered critical for smooth implementation. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR |
| container_issue |
3 |
| title_short |
Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations |
| url |
https://doi.org/10.1016/j.vaccine.2020.12.003 |
| remote_bool |
true |
| author2 |
Ivol, Sabrina Oriol Mathieu, Valérie Erismann, Séverine Prytherch, Helen Steinmann, Peter |
| author2Str |
Ivol, Sabrina Oriol Mathieu, Valérie Erismann, Séverine Prytherch, Helen Steinmann, Peter |
| ppnlink |
ELV007884451 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.vaccine.2020.12.003 |
| up_date |
2024-07-06T16:40:43.366Z |
| _version_ |
1803848561057595392 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV052624242</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624185024.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.vaccine.2020.12.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001252.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV052624242</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0264-410X(20)31566-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">48.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Greter, Helena</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Heterologous vaccine regimens provide a new approach for disease prevention. • Anticipating licensure of such vaccines, perceived benefits and challenges for acceptance were assessed. • Respondents rated improved efficacy and duration of protection, compared to established vaccines, as expected benefits. • Logistics, protocol adherence, and compliance were considered key areas for roll-out. • A clear communication strategy, adjusted to different stakeholders, was considered critical for smooth implementation.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Heterologous vaccine regimen</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Acceptance</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Implementation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ivol, Sabrina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Oriol Mathieu, Valérie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Erismann, Séverine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Prytherch, Helen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steinmann, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Li, Yaoyao ELSEVIER</subfield><subfield code="t">Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV007884451</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:3</subfield><subfield code="g">day:15</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:580-587</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.vaccine.2020.12.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-FOR</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">48.00</subfield><subfield code="j">Land- und Forstwirtschaft: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2021</subfield><subfield code="e">3</subfield><subfield code="b">15</subfield><subfield code="c">0115</subfield><subfield code="h">580-587</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.4018154 |